Toxicology
Terminology in dose response
LD50: median lethal dose (mg per kg bodyweight)
- ED50: median effect dose (mg per kg bodyweight)
- LOAEL: lowest observed adverse effect level (dose)
- NOAEL: no observed adverse effect level (dose)
- LC50: median lethal concentration in water, air, soil (μg/L, μg/m3, mg/kg)
- EC50: median effect concentration
- LOEC: lowest observed effect concentration
- NOEC: no observed effect concentration
- CES: critical effect size
- BMDL: benchmark dose lower confidence bound
Lecture 02
Toxicology in science
Alkaloids from hemlock (Coniine) block the acetylcholine-receptor in neurons of the autonomous
nervous system.
Paracelsus is the luther of medicine. He took the compound (toxicon) as starting point and not the
mixture. Points of departure:
- Experimenting is essential
- Distinguish between poisonous and therapeutic properties
- These cannot always be distinguished
- Compounds may have specific effect
All things are poisonous and nothing is not poisonous only the dose makes something not being a
poison.
General principles
Phases in toxic response:
- Exposure
o External exposure (ug/l water, ug/m3 air)
o Dose (ug/kg bodyweight)
o Internal exposure (ug/l blood, ug/kg fat)
- Toxicokinetics: what does body do to the compound (ADME)
o Absorption, Distribution, Metabolism (biotransformation), Elimination (excretion)
- Toxicodynamics: what does compound do to body
o Irritation, inflammation, corrosion, narcosis, carcinogenesis etc.
o Will be dealt with for different group of compounds
Human exposure routes:
- Oral
- Dermal
- Respiratory
- Special routes (injection, intravenous therapy)
,Classification of toxic effects
- Rate
o Acute effect
o Chronic effect (carcinogenesis)
- Possibility for repair
o Reversible (DNA damage)
o Irreversible (tumor progression)
- Site of action
o Local effect at site of first contact
o Systemic effect
Target organs, CNS, circulatory system, skin
Unborn embryo
Example of systemic toxicity
- Developmental toxicity
- Softenon-baby, very serious structural birth defects related to use of thalidomide during
pregnancy.
- Thalidomide is teratogenic causing:
o Amelia: absence of limbs
o Phocomelia: reduction of long bones of limbs
Acute vs chronic toxicity:
- Acute toxicity occurs soon after a short exposure to a compound
- Chronic toxicity occurs after repeated, longterm exposure to a compound.
Toxicity test – endpoints:
- Specific endpoints
o Gene expression
o Enzyme activity
o Neurotransmission
o Histological tissue examination
- General endpoints (important for population)
o Survival
o Growth/metabolism
o Reproduction
o Behavior
Toxicity test – how:
- In vivo testing
o Model species applicable to humans (mouse, rat, pig, zebrafish)
o Model species representing ecological food chain (algae, fish, macrophytes)
o Alternative models (nematode worms, zebrafish embryos)
- In vitro testing
o Protein-based, cell-based systems
- Human epidemiological studies
o Not testing
o Studying the human population
- In silico testing:
, o Quantitative structure activity relationships (QSAR), Read Across, in vitro-in vivo
extrapolation (IVIVE)
Toxicity test in practice:
- Negative control (C0)
- Series of increasing test concentrations or doses (C1-Cn)
- Positive control (Cp)
Dose-response curves
Dose response curve:
- Forward use
o From X-as to Y-as, so what doses gives what response
o To predict effect size and risk
- Backward use
o From Y-as to X-as,
o To express the measure of effect caused by a mixture with unknown composition in
terms of a dose of a single reference compound causing exactly the same response
level (“equivalent dose”)
o To derive compound characteristics
o Threshold values
o Risk assessment
CES: Critical effect size
CED: Critical effect dose
BMD: Benchmark dose
CI: Confidence interval
BMDL: Benchmark dose lower confidence bound
LD50: Median lethal dose
- If it is high, it is not toxic
- If the dose is low, it is very toxic
Potency and efficacy:
- In a curve. Most left.
o High effect with low dose. Low EC50
- Most right:
o Needs higher dose to have an effect. High EC50.
Three characteristics of curve
- Location of x-as (ED50, potency)
- Maximum response on y-as (effectiveness)
- Steepness of curve
Critisicim on NOAEL and LOAEL:
- NOAEL: No Observed Adverse Effect Level.
o Depends on:
Replicates
Variation in replicates
Dose interval
Statistical test and p-value
Les avantages d'acheter des résumés chez Stuvia:
Qualité garantie par les avis des clients
Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.
L’achat facile et rapide
Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.
Focus sur l’essentiel
Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.
Foire aux questions
Qu'est-ce que j'obtiens en achetant ce document ?
Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.
Garantie de remboursement : comment ça marche ?
Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.
Auprès de qui est-ce que j'achète ce résumé ?
Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur Deemm94. Stuvia facilite les paiements au vendeur.
Est-ce que j'aurai un abonnement?
Non, vous n'achetez ce résumé que pour €2,99. Vous n'êtes lié à rien après votre achat.